Document Detail

Down-regulation of P-glycoprotein is associated with resistance to cisplatin and VP-16 in human lung cancer cell lines.
MedLine Citation:
PMID:  20944142     Owner:  NLM     Status:  MEDLINE    
AIM: To investigate whether down-regulation of P-glycoprotein (P-gp) is correlated to resistance to cisplatin and VP-16 in four histopathological subtype cell lines of lung cancer (SK-MES-1, SPCA-1, NCI-H-460 and NCI-H-446). MATERIALS AND METHODS: After pretreatment with or without verapamil, the P-gp expression was examined by means of RT-PCR and immunofluorescence. Cell survival on treatment with cisplatin and VP-16 was determined by MTT assay. RESULTS: The expression of P-gp was clearly inhibited by verapamil in all four cell lines. Following pretreatment with verapamil, NCI-H-446 was more sensitive to cisplatin, while SPCA-1, NCI-H-460 and NCI-H-446 were more sensitive to VP-16 compared to the control. CONCLUSION: Down-regulation of P-gp is associated with intrinsic resistance to cisplatin in the NCI-H-446 and to VP-16 in SPCA-1, NCI-H-460 and NCI-H-446 cell lines. These findings indicate that down-regulation of P-gp may be helpful for the reversion of drug resistance in some lung cancer cell line subtypes.
Jiarui Wang; Huiling Wang; Long Zhao; Sufang Fan; Zhonghai Yang; Fei Gao; Lixia Chen; Gary Guishan Xiao; Joseph Molnár; Qi Wang
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anticancer research     Volume:  30     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-10-14     Completed Date:  2010-11-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  3593-8     Citation Subset:  IM    
1Graduate School of Dalian Medical University, Dalian 116044, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / pharmacology*
Cell Line, Tumor
Cisplatin / pharmacology
Drug Resistance, Neoplasm / genetics*
Etoposide / pharmacology
Fluorescent Antibody Technique
Lung Neoplasms / genetics,  metabolism*
P-Glycoprotein / biosynthesis*,  genetics
Reverse Transcriptase Polymerase Chain Reaction
Reg. No./Substance:
0/Antineoplastic Agents; 0/P-Glycoprotein; 15663-27-1/Cisplatin; 33419-42-0/Etoposide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of Ha-rasval12 on nm23 Expression, Tumor Formation and Metastasis of the Transformants, and I...
Next Document:  A Dihydroxy-pentamethoxyflavone from Gardenia obtusifolia suppresses proliferation and promotes apop...